Series A funding round for Volastra Therapeutics raising $60M in March 2023
Series A funding round for Volastra Therapeutics raising $60M in March 2023
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
Eli LillyLEAD | Public | — |
| Private | — | |
Eli LillyLEAD | Angel | Eli Lilly |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| University Fund | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$104M
Top Valuation
-
Volastra Therapeutics raised $60M in a Series A round.
The round was announced on 03/01/23.
The round was led by ARCH Venture Partners, Eli Lilly and Company, Polaris Partners.